Literature DB >> 17981517

Liver mtDNA content increases during development: a comparison of methods and the importance of age- and tissue-specific controls for the diagnosis of mtDNA depletion.

Karl J Morten1, Neil Ashley, Frits Wijburg, Nedim Hadzic, Jeremy Parr, Sandeep Jayawant, Susan Adams, Laurence Bindoff, Henk D Bakker, Giorgina Mieli-Vergani, Massimo Zeviani, Joanna Poulton.   

Abstract

BACKGROUND: The quantitative loss of mitochondrial DNA (mtDNA) known as mtDNA depletion, often gives rise to liver disease. The diagnosis of mtDNA depletion syndrome is frequently imprecise, both for technical reasons and because of the lack of established age-adjusted normal ranges. We aimed to refine quantitative methods for diagnosing the hepatic type of mtDNA depletion syndrome, firstly by establishing an age-matched reference range for mitochondrial to nuclear DNA ratio (henceforth "mtDNA content") and secondly by investigating mtDNA in fibroblasts.
METHODS: By comparing realtime PCR with an established method for quantifying mtDNA content we established a reference range for young children using biopsy and post-mortem material from patients <15 years. In addition, we investigated the arrangement of mtDNA in nucleoids from fibroblasts using fluorescence microscopy.
RESULTS: Both methods showed that the mtDNA content of liver increases rapidly over the perinatal period. In a patient whose liver mtDNA content fell, but remained within the reference range, early investigation and age-matched controls were essential, as we found a progressive increase in muscle mtDNA copy number, respiratory chain activity and muscle power with age. In three further patients, fluorescence microscopy of the fibroblasts proved diagnostic. In one case a movement disorder was an important pointer.
CONCLUSIONS: These cases highlight the (i) need for comparing mtDNA copy number data generated from patients to DNA isolated from an age-matched normal range from the tissue of interest and (ii) the utility of mtDNA staining with PicoGreen as a method to detect aberrant nucleoid morphology in mtDNA depletion patient fibroblast lines when affected tissues are not available for measuring mtDNA copy number.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17981517     DOI: 10.1016/j.mito.2007.09.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  17 in total

1.  Quantitative Analysis of mtDNA Content in Formalin-Fixed Paraffin-Embedded Muscle Tissue.

Authors:  Aida Font; Frederic Tort; Aleix Navarro-Sastre; Victòria Cusí; Judit García-Villoria; Paz Briones; Antonia Ribes
Journal:  JIMD Rep       Date:  2011-06-22

Review 2.  Reversible infantile mitochondrial diseases.

Authors:  Veronika Boczonadi; Boglarka Bansagi; Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2014-11-19       Impact factor: 4.982

3.  Mitochondrial DNA Depletion and Deletions in Paediatric Patients with Neuromuscular Diseases: Novel Phenotypes.

Authors:  Tuomas Komulainen; Milla-Riikka Hautakangas; Reetta Hinttala; Salla Pakanen; Vesa Vähäsarja; Petri Lehenkari; Päivi Olsen; Päivi Vieira; Outi Saarenpää-Heikkilä; Johanna Palmio; Hannu Tuominen; Pietari Kinnunen; Kari Majamaa; Heikki Rantala; Johanna Uusimaa
Journal:  JIMD Rep       Date:  2015-05-05

4.  Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.

Authors:  Peng Xia; Han-Xiang An; Cheng-Xue Dang; Ramin Radpour; Corina Kohler; Emmanouil Fokas; Rita Engenhart-Cabillic; Wolfgang Holzgreve; Xiao Yan Zhong
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

Review 5.  Number matters: control of mammalian mitochondrial DNA copy number.

Authors:  Laura L Clay Montier; Janice J Deng; Yidong Bai
Journal:  J Genet Genomics       Date:  2009-03       Impact factor: 4.275

6.  Modeling RNA polymerase interaction in mitochondria of chordates.

Authors:  Vassily A Lyubetsky; Oleg A Zverkov; Sergey A Pirogov; Lev I Rubanov; Alexandr V Seliverstov
Journal:  Biol Direct       Date:  2012-08-09       Impact factor: 4.540

7.  Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India.

Authors:  Rosy Mondal; Sankar Kumar Ghosh; Javed Hussain Choudhury; Anil Seram; Kavita Sinha; Marine Hussain; Ruhina Shirin Laskar; Bijuli Rabha; Pradip Dey; Sabitri Ganguli; Monisha Nathchoudhury; Fazlur Rahman Talukdar; Biswadeep Chaudhuri; Bishal Dhar
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.

Authors:  Neil Ashley; Anthony O'Rourke; Conrad Smith; Susan Adams; Vasantha Gowda; Massimo Zeviani; Garry K Brown; Carl Fratter; Joanna Poulton
Journal:  Hum Mol Genet       Date:  2008-05-16       Impact factor: 6.150

9.  Prospective study of POLG mutations presenting in children with intractable epilepsy: prevalence and clinical features.

Authors:  Johanna Uusimaa; Vasantha Gowda; Anthony McShane; Conrad Smith; Julie Evans; Annie Shrier; Manisha Narasimhan; Anthony O'Rourke; Yusuf Rajabally; Tammy Hedderly; Frances Cowan; Carl Fratter; Joanna Poulton
Journal:  Epilepsia       Date:  2013-02-28       Impact factor: 5.864

10.  Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy.

Authors:  Rita Horvath; John P Kemp; Helen A L Tuppen; Gavin Hudson; Anders Oldfors; Suely K N Marie; Ali-Reza Moslemi; Serenella Servidei; Elisabeth Holme; Sara Shanske; Gittan Kollberg; Parul Jayakar; Angela Pyle; Harold M Marks; Elke Holinski-Feder; Mena Scavina; Maggie C Walter; Jorida Coku; Andrea Günther-Scholz; Paul M Smith; Robert McFarland; Zofia M A Chrzanowska-Lightowlers; Robert N Lightowlers; Michio Hirano; Hanns Lochmüller; Robert W Taylor; Patrick F Chinnery; Mar Tulinius; Salvatore DiMauro
Journal:  Brain       Date:  2009-08-31       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.